Director, Publications and Scientific Communications

About Eidos Therapeutics & BridgeBio Pharma

Eidos Therapeutics, an affiliate of BridgeBio Pharma, is a Phase 3 developmental-stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. We seek to treat this well-defined family of diseases at their collective source by stabilizing TTR. Our investigational product, acoramidis (AG10), is an orally administered small molecule designed to potently stabilize TTR, a potentially best-in-class treatment aiming to halt the progression of ATTR diseases.

BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 30+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs. 

Our focus on scientific excellence and rapid execution aims to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, and Raleigh, with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zurich, Switzerland, and are expanding across Europe. 

To learn more about our story and company culture, visit us at eidostx.com/ | https://bridgebio.com

Who You Are

The Director, Publications and Scientific Communications will be responsible for the development and tactical execution of publications, scientific communication, and scientific training materials. This role ensures the quality and compliance of scientific and medical documents, aligning publication initiatives with organizational goals and medical strategic imperatives.

You will report to the Executive Director, Scientific Communications & Publications, Medical Affairs.

Responsibilities

• Act as a point person and lead the development and execution of the integrated strategic publication plans for Evidence Generation publications and provide support for clinical publications
• Provide strategic and technical leadership in planning and driving the timely publications (abstracts, posters, presentations, manuscripts, and publication enhancers)
• Lead scientific content development and oversee writing projects (manuscripts, abstracts, posters, presentations, publication enhancers) from planning to submission
• Review tactics for messaging/lexicon alignment, scientific accuracy, appropriateness for audience, quality, and provide direction to medical communication agencies during development, and reviews
• Provide ideas for generating publications to fill scientific knowledge gaps
• Develop and maintain effective working relationships with internal (biostatistics, clinical development, evidence generation, and medical team) partners/authors and external experts/authors (key opinion leaders, investigators)
• Partner with regional medical directors to drive medical training decks for all publications and FAQs for high-priority or critical publications
• May have to occasionally write abstracts, congress presentations, as well as certain sections of the manuscripts
• Manage cross-functional teams for publications planning, review, and medical trainings
• Build and maintain timelines, ensuring high-quality deliverables within budget
• Manage external medical communications agencies
• Ability to be agile, while ensuring compliance with internal BridgeBio Publications Policy and SOPs, external publication guidelines, and industry best practices, e.g. GPP, ICMJE, CONSORT, PRISMA, etc.
• This role requires regular engagement with Executive leaders, so the ability to communicate effectively and succinctly with senior leaders is essential

No matter your role at BridgeBio, successful team members are:

• Patient Champions, who put patients first and uphold strict ethical standards
• Entrepreneurial Operators, who drive toward practical solutions and have an ownership mindset
• Truth Seekers, who are detailed, rational, and humble problem solvers
• Individuals Who Inspire Excellence in themselves and those around them
• High-quality executors, who execute against goals and milestones with quality, precision, and speed

Education, Experience & Skills Requirements

• Education: Advanced degree (PhD in biological science, PharmD, MD, or equivalent) required
• 10+ years in medical affairs in the pharmaceutical/biotech industry with a strong medical/scientific focus in the Director role
• ISMPP CMPP^TM credential is required for this role
• Experience in cardiology and/or rare diseases preferred
• Prior medical writing experience preferred
• Ability to understand and interpret medical data, with general knowledge of statistical concepts and techniques
• Knowledge of GPP, ICMJE, AMWA guidelines and industry best practices that apply to the development of scientific publications and be able to provide guidance as needed to cross-functional and global stakeholders
• Familiarity with publication management systems (e.g., Datavision/iEnvision) preferred
• Strong writing, communication, and project management skills. Demonstrated success in creating and delivering effective presentations to senior-level audiences and to external or internal authors
• Solution-oriented, with a keen eye to foresee and address potential publication-related issues, or mediate solutions to resolve conflicting comments
• Proven ability to work in fast-paced, collaborative environments
• Ability to travel up to 25% to various profession meetings, mainly US; however, some international travel may be required

What We Offer

• Patient Days, where we are fortunate to hear directly from individuals living with the conditions we are seeking to impact throughout the year and learn how we can improve our efforts
• A culture inspired by our values: put patients first, think independently, be radically transparent, every minute counts, and let the science speak
• An unyielding commitment to always putting patients first. Learn more about how we do this here
• A de-centralized model that enables our program teams to focus on advancing science and helping patients. Our affiliate structure is designed to eliminate bureaucracy and put decision-making power in the hands of those closest to the science
• A place where you own the vision – both for your program and your own career path
• A collaborative, fast-paced, data-driven environment where we inspire ourselves and each other to always perform at the top of our game
• Access to learning and development resources to help you get in the best professional shape of your life
• Robust and market-competitive compensation & benefits package (Base, Performance Bonus, Equity, health, welfare & retirement programs)
• Flexible PTO
• Rapid career advancement for strong performers
• Potential ability to work on multiple BridgeBio Pharma programs across multiple therapeutic areas over time 
• Partnerships with leading institutions
• Commitment to Diversity, Equity & Inclusion